Tenon Medical, Inc. financial data

Symbol
TNON, TNONW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
104 Cooper Ct., Los Gatos, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 159 % -42.1%
Quick Ratio 19.1 % +15.8%
Debt-to-equity 257 % +177%
Return On Equity -716 % -100%
Return On Assets -200 % -7.93%
Operating Margin -412 % +66.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.95M shares -82.5%
Common Stock, Shares, Outstanding 3.78M shares -82.5%
Entity Public Float 4.89M USD -72.1%
Common Stock, Value, Issued 4K USD -81.8%
Weighted Average Number of Shares Outstanding, Basic 3.75K shares +187%
Weighted Average Number of Shares Outstanding, Diluted 3.75K shares +187%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.37M USD +103%
Cost of Revenue 1.34M USD -26.3%
Research and Development Expense 2.81M USD -16.1%
Selling and Marketing Expense 5.7M USD -40.2%
General and Administrative Expense 7.43M USD +0.69%
Operating Income (Loss) -13.9M USD +31.9%
Nonoperating Income (Expense) 29K USD -86%
Net Income (Loss) Attributable to Parent -13.9M USD +31.3%
Earnings Per Share, Basic -3.28 USD/shares +88.4%
Earnings Per Share, Diluted -3.28 USD/shares +88.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.97M USD -66.4%
Accounts Receivable, after Allowance for Credit Loss, Current 679K USD +13%
Inventory, Net 609K USD +6.84%
Assets, Current 4.09M USD -48.5%
Property, Plant and Equipment, Net 904K USD -4.34%
Operating Lease, Right-of-Use Asset 525K USD -31.1%
Assets 6.01M USD -39.1%
Accounts Payable, Current 1.11M USD +21.8%
Employee-related Liabilities, Current 531K USD
Accrued Liabilities, Current 932K USD -17.5%
Liabilities, Current 3.4M USD -50.4%
Operating Lease, Liability, Noncurrent 290K USD -48.2%
Liabilities 5.17M USD -42.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -46K USD +54%
Retained Earnings (Accumulated Deficit) -62.5M USD -28.5%
Stockholders' Equity Attributable to Parent 832K USD -7.86%
Liabilities and Equity 6.01M USD -39.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.34M USD +34.6%
Net Cash Provided by (Used in) Financing Activities 4.37M USD
Net Cash Provided by (Used in) Investing Activities -119K USD -103%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 3.78M shares -82.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.96M USD +86.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.97M USD -66.4%
Deferred Tax Assets, Valuation Allowance 12.4M USD +45.2%
Deferred Tax Assets, Gross 12.6M USD +42.5%
Operating Lease, Liability 561K USD -30.1%
Depreciation 86K USD +146%
Payments to Acquire Property, Plant, and Equipment 84K USD -34.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.83M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid 608K USD -32.8%
Property, Plant and Equipment, Gross 1.35M USD
Operating Lease, Liability, Current 271K USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 144K USD -52.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 310K USD +107%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47K USD -54.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 144K USD -53.5%
Deferred Tax Assets, Operating Loss Carryforwards 9.5M USD +35.8%
Unrecognized Tax Benefits 79K USD +108%
Lessee, Operating Lease, Liability, to be Paid, Year Four 144K USD 0%
Operating Lease, Payments 74K USD +2.78%
Additional Paid in Capital 60M USD +21.1%
Depreciation, Depletion and Amortization 100K USD +300%
Deferred Tax Assets, Net of Valuation Allowance 178K USD -38%
Share-based Payment Arrangement, Expense 4.12M USD +28.2%
Interest Expense 34K USD